Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 31, 2023

Apotex Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has one hundred and thirty-three approved drugs.

There are twenty-one tentative approvals on APOTEX INC drugs.

Summary for Apotex Inc

US Patents:	0
Tradenames:	106
Ingredients:	102
NDAs:	133
Drug Master File Entries:	2
Patent Litigation for Apotex Inc:	See patent lawsuits for Apotex Inc
PTAB Cases with Apotex Inc as petitioner:	See PTAB cases with Apotex Inc as petitioner

Drugs and US Patents for Apotex Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Inc	CLOPIDOGREL BISULFATE	clopidogrel bisulfate	TABLET;ORAL	076274-001	May 17, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Apotex Inc	OLANZAPINE	olanzapine	TABLET;ORAL	090798-006	Apr 23, 2012	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Apotex Inc	RISPERIDONE	risperidone	TABLET;ORAL	077953-005	Sep 15, 2008	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Apotex Inc	DESMOPRESSIN ACETATE	desmopressin acetate	TABLET;ORAL	077414-002	Mar 7, 2006	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Apotex Inc	BIMATOPROST	bimatoprost	SOLUTION/DROPS;TOPICAL	201894-001	Dec 1, 2014	AT	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Apotex Inc	BUPROPION HYDROCHLORIDE	bupropion hydrochloride	TABLET;ORAL	076143-002	Jan 17, 2006	AB	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Boehringer Ingelheim

Johnson and Johnson

Moodys

Mallinckrodt

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.